Real-time Estimate
Other stock markets
|
5-day change | 1st Jan Change | ||
83.4 EUR | +0.18% | -2.41% | -3.12% |
Strengths
- The company's profit outlook over the next few years is a strong asset.
- The company's EBITDA/Sales ratio is relatively high and results in high margins before depreciation, amortization and taxes.
- The company returns high margins, thereby supporting business profitability.
- Analysts have a positive opinion on this stock. Average consensus recommends overweighting or purchasing the stock.
- Analyst opinion has improved significantly over the past four months.
- Over the past twelve months, analysts' opinions have been strongly revised upwards.
- Predictions on business development from analysts polled by Standard & Poor's are tight. This results from either a good visibility into core activities or accurate earnings releases.
Weaknesses
- With an expected P/E ratio at 40.98 and 29.11 respectively for both the current and next fiscal years, the company operates with high earnings multiples.
- The company's "enterprise value to sales" ratio is among the highest in the world.
- The valuation of the company is particularly high given the cash flows generated by its activity.
- The company is not the most generous with respect to shareholders' compensation.
- For the past year, analysts have significantly revised downwards their profit estimates.
- The group usually releases earnings worse than estimated.
Ratings chart - Surperformance
Sector: Medical Equipment, Supplies & Distribution
1st Jan change | Capi. | Investor Rating | ESG Refinitiv | |
---|---|---|---|---|
-3.12% | 17.76B | - | ||
+22.09% | 44.27B | B | ||
-30.03% | 1.93B | D+ | ||
+11.49% | 1.87B | C+ | ||
+22.32% | 1.16B | - | ||
+75.35% | 659M | - | - | |
-12.09% | 634M | - | ||
-44.04% | 633M | B- | ||
-48.16% | 604M | - | ||
+31.11% | 551M | - |
Financials
Valuation
Momentum
Consensus
Business Predictability
Technical analysis
- Stock Market
- Equities
- COO Stock
- CP60 Stock
- Ratings The Cooper Companies, Inc.